You can find more information about PF3D7_0610800-Transketolase using the following links:

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
(E)-1-(2,4-dinitrophenyl)-2-((10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-1,2,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-ylidene)hydrazine	Structure based design, stability study and synthesis of the dinitrophenylhydrazone derivative of the oxidation product of lanosterol as a potential P. falciparum transketolase inhibitor and in-vivo antimalarial study(2021)
6'-Methyl-Thiamin Diphosphate	Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment(2015)
7-hydroxy-5-methyl-2-(2-oxopropyl)-8-((1S,2S,3R,4R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl)-4H-chromen-4-one	Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study(2020)
Molecular biology, suggested target	Molecular cloning and characterization of Plasmodium falciparum transketolase(2008)